1.During the quarter under rewiew, the Incomeof the company has grown by 20% and Profit before tax has shown an increse of 16% as compared to the same period in the previous year.
2.The company is exclusively in the Pharmaceutical business segment only.
3.Information on Investor's Complaints for the quarter: Opening: nil, Resolved: 6, Pending: Nil
4.The above results were taken on record by the Audit Committee and Board of Directors at their their respective meetings held on 30th January,2008. |